What is GIPL's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.02B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for GIPL?

P/E (TTM) is n/a and 52-week range is $0.11 to $0.99 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s GIPL figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for GIPL?

The company profile lists revenue (TTM) near $187K, net income (TTM) near $-717K, EPS (TTM) near $-0.01 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Global Innovative Platforms Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Maitland, Florida, US, 49.1M shares outstanding, ISIN US37960M1018 when available from company profile and filing metadata.

Global Innovative Platforms Inc

$GIPL

Health Care · Health Care Equipment & Supplies

Run Scenarios

$0.50

+0.00%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Global Innovative Platforms, Inc. is a development-stage company focused on advancing diagnostic technologies in the animal health sector. The company is headquartered in Maitland, Florida. The company went IPO on 2003-12-23. The firm develops non-invasive diagnostic tools for detecting diseases, assessing treatment effectiveness, and monitoring potentially toxic environmental and food conditions. Its proprietary technologies, VOCAM Plus and the FROG, utilize advanced gas chromatography and artificial intelligence (AI) software to provide rapid breath and air analysis. VOCAM technology consists of two components: one which it is developing to collect the samples, and a second component to process and analyze breath samples that indicate multiple volatile organic compounds (VOC) on a single reading to measure a variety of potential threats, including its initial focus on the heartworm market. FROG utilizes similar technology as the VOCAM Plus, but it also includes a collection wand, to collect samples, eliminating the need for an external water, soil, feed, or air collection device.

Website

ir.giplinc.com/

IPO

2003-12-23

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)